These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 20361940

  • 1. Regulation of survivin by PI3K/Akt/p70S6K1 pathway.
    Zhao P, Meng Q, Liu LZ, You YP, Liu N, Jiang BH.
    Biochem Biophys Res Commun; 2010 Apr 30; 395(2):219-24. PubMed ID: 20361940
    [Abstract] [Full Text] [Related]

  • 2. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
    Meng Q, Xia C, Fang J, Rojanasakul Y, Jiang BH.
    Cell Signal; 2006 Dec 30; 18(12):2262-71. PubMed ID: 16839745
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells.
    Ikezoe T, Nishioka C, Bandobashi K, Yang Y, Kuwayama Y, Adachi Y, Takeuchi T, Koeffler HP, Taguchi H.
    Leuk Res; 2007 May 30; 31(5):673-82. PubMed ID: 17007924
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation.
    Roca H, Varsos Z, Pienta KJ.
    J Biol Chem; 2008 Sep 05; 283(36):25057-73. PubMed ID: 18611860
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of the Akt/survivin pathway synergizes the antileukemia effect of nutlin-3 in acute lymphoblastic leukemia cells.
    Zhu N, Gu L, Li F, Zhou M.
    Mol Cancer Ther; 2008 May 05; 7(5):1101-9. PubMed ID: 18483299
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.
    Zhou C, Qiu L, Sun Y, Healey S, Wanebo H, Kouttab N, Di W, Yan B, Wan Y.
    Int J Oncol; 2006 Jul 05; 29(1):269-78. PubMed ID: 16773209
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway.
    Lee KW, Yook JY, Son MY, Kim MJ, Koo DB, Han YM, Cho YS.
    Stem Cells Dev; 2010 Apr 05; 19(4):557-68. PubMed ID: 19642865
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin.
    Fetz V, Bier C, Habtemichael N, Schuon R, Schweitzer A, Kunkel M, Engels K, Kovács AF, Schneider S, Mann W, Stauber RH, Knauer SK.
    Int J Cancer; 2009 May 01; 124(9):2033-41. PubMed ID: 19130609
    [Abstract] [Full Text] [Related]

  • 18. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
    Liu F, Liu S, He S, Xie Z, Zu X, Jiang Y.
    Oncol Rep; 2010 May 01; 23(5):1469-75. PubMed ID: 20372866
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.